The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial
Authors:
- 13 July 2017
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 130 (2) , 214-220
Abstract
The effect of variation in platelet function in platelet donors on patient outcome following platelet transfusion is unknown. This trial assessed the hypothesis that platelets collected from donors with highly responsive platelets to agonists in vitro assessed by flow cytometry (high-responder donors) are cleared more quickly from the circulation than those from low-responder donors, resulting in lower platelet count increments following transfusion. This parallel group, semirandomized double-blinded trial was conducted in a single center in the United Kingdom. Eligible patients were those 16 or older with thrombocytopenia secondary to bone marrow failure, requiring prophylactic platelet transfusion. Patients were randomly assigned to receive a platelet donation from a high- or low-responder donor when both were available, or when only 1 type of platelet was available, patients received that. Participants, investigators, and those assessing outcomes were masked to group assignment. The primary end point was the platelet count increment 10 to 90 minutes following transfusion. Analysis was by intention to treat. Fifty-one patients were assigned to receive platelets from low-responder donors, and 49 from high-responder donors (47 of which were randomized and 53 nonrandomized). There was no significant difference in platelet count increment 10 to 90 minutes following transfusion in patients receiving platelets from high-responder (mean, 21.0 × 109/L; 95% confidence interval [CI], 4.9-37.2) or low-responder (mean, 23.3 × 109/L; 95% CI, 7.8-38.9) donors (mean difference, 2.3; 95% CI, −1.1 to 5.7; P = .18). These results support the current policy of not selecting platelet donors on the basis of platelet function for prophylactic platelet transfusion. Publisher9s Note: There is an Inside Blood Commentary on this article in this issue. Key Points There is variation in platelet function between normal individuals, and this function is consistent within the same individual over time. The data from this study suggest that variation in donor platelet function does not affect the outcome of prophylactic transfusion.Keywords
This publication has 21 references indexed in Scilit:
- Application of reticulated platelets to transfusion management during autologous stem cell transplantationOncoTargets and Therapy, 2012
- Platelet transfusions for patients with haematological malignancies: who needs them?British Journal of Haematology, 2011
- Apheresis donors and platelet function: inherent platelet responsiveness influences platelet qualityTransfusion, 2008
- Feasibility and usefulness of self‐assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleedingVox Sanguinis, 2006
- Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantationTransfusion Medicine, 2006
- Role of platelet surface glycoprotein Ibα and P‐selectin in the clearance of transfused platelet concentratesTransfusion, 2004
- Seven‐day storage of single‐donor platelets: recovery and survival in an autologous transfusion studyTransfusion, 2002
- Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresisTransfusion, 1992
- Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusionTransfusion, 1991
- Epinephrine‐induced platelet aggregation. A twin study**Clinical Genetics, 1984